These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Review of the current status of prokinetic agents in gastroenterology. McCallum RW Am J Gastroenterol; 1985 Dec; 80(12):1008-16. PubMed ID: 4072997 [No Abstract] [Full Text] [Related]
3. [Pharmacologic and clinical differentiation of prokinetic drugs]. May B; Greving I Leber Magen Darm; 1996 Jul; 26(4):193-8. PubMed ID: 8965601 [TBL] [Abstract][Full Text] [Related]
4. Prokinetic agents: a key in the future of gastroenterology. Reynolds JC Gastroenterol Clin North Am; 1989 Jun; 18(2):437-57. PubMed ID: 2668178 [TBL] [Abstract][Full Text] [Related]
5. Gastric emptying in gastroesophageal reflux and the therapeutic role of prokinetic agents. McCallum RW Gastroenterol Clin North Am; 1990 Sep; 19(3):551-64. PubMed ID: 1977702 [TBL] [Abstract][Full Text] [Related]
6. Drug therapy. Metoclopramide. Schulze-Delrieu K N Engl J Med; 1981 Jul; 305(1):28-33. PubMed ID: 7015140 [No Abstract] [Full Text] [Related]
7. The current status of gastric prokinetic drugs. Schapira M; Henrion J; Heller FR Acta Gastroenterol Belg; 1990; 53(4):446-57. PubMed ID: 1982914 [TBL] [Abstract][Full Text] [Related]
8. [Prokinetic drugs]. Hellström P Nord Med; 1992; 107(11):274-7. PubMed ID: 1448341 [TBL] [Abstract][Full Text] [Related]
10. Effects of mosapride citrate, metoclopramide hydrochloride, lidocaine hydrochloride, and cisapride citrate on equine gastric emptying, small intestinal and caecal motility. Okamura K; Sasaki N; Yamada M; Yamada H; Inokuma H Res Vet Sci; 2009 Apr; 86(2):302-8. PubMed ID: 18723200 [TBL] [Abstract][Full Text] [Related]
11. Metoclopramide: a dopamine receptor antagonist. DiPalma JR Am Fam Physician; 1990 Mar; 41(3):919-24. PubMed ID: 2407079 [TBL] [Abstract][Full Text] [Related]
12. Effects of an Atractylodes lancea rhizome extract and a volatile component β-eudesmol on gastrointestinal motility in mice. Kimura Y; Sumiyoshi M J Ethnopharmacol; 2012 May; 141(1):530-6. PubMed ID: 22374082 [TBL] [Abstract][Full Text] [Related]
13. Role of prokinetic drugs for treatment of postoperative ileus in the horse. Dart AJ; Hodgson DR Aust Vet J; 1998 Jan; 76(1):25-31. PubMed ID: 9578763 [TBL] [Abstract][Full Text] [Related]
14. Use of prokinetic agents in special populations. Horn JR Am J Health Syst Pharm; 1996 Nov; 53(22 Suppl 3):S27-9. PubMed ID: 8931828 [TBL] [Abstract][Full Text] [Related]
16. [Prokinetic agents--their contribution to practice of gastroenterology]. Hep A; Dolina J Vnitr Lek; 2011 Sep; 57(9):693-6. PubMed ID: 21957760 [TBL] [Abstract][Full Text] [Related]
17. The riddle, mystery, and enigma of gastroparesis. Pasricha PJ J Support Oncol; 2007 Sep; 5(8):368-70. PubMed ID: 17944145 [No Abstract] [Full Text] [Related]
18. Motility disorders in the ICU: recent therapeutic options and clinical practice. Röhm KD; Boldt J; Piper SN Curr Opin Clin Nutr Metab Care; 2009 Mar; 12(2):161-7. PubMed ID: 19202387 [TBL] [Abstract][Full Text] [Related]
19. Prokinetics in the Management of Functional Gastrointestinal Disorders. Quigley EMM Curr Gastroenterol Rep; 2017 Sep; 19(10):53. PubMed ID: 28887755 [TBL] [Abstract][Full Text] [Related]
20. [The potentials of erythromycin derivatives in the treatment of gastrointestinal motility disorders]. Peeters TL Z Gesamte Inn Med; 1991 Aug; 46(10-11):349-54. PubMed ID: 1926941 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]